Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Rheumatology International|November 10, 2021
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional studyPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.Lancet (London, England)|October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trialIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.Health Technology Assessment (Winchester, England)|March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluationIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.Archives of Medical Science : AMS|September 21, 2023
Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studiesPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.Biomarker Insights|February 7, 2022
Relationship Between Anti-DFS70 Autoantibodies and Oxidative StressPaweł Krzemień, Sławomir Kasperczyk, Maciej Banach, et al.European Journal of Preventive Cardiology|April 11, 2023
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studiesKamila Osadnik, Tadeusz Osadnik, Marek Gierlotka, et al.Journal of Clinical Medicine|October 13, 2021
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 StudyBeata Labuz-Roszak, Maciej Banach, Michal Skrzypek, et al.Journal of Clinical Medicine|December 10, 2021
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 StudyKrzysztof Studziński, Tomasz Tomasik, Adam Windak, et al.European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.Diabetologia|December 8, 2014
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysisDaniel Levin, Samira Bell, Reijo Sund, et al.Pageof 15